Clinical Trials
160 trialsCamrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC
Guangdong Association of Clinical Trials
Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma
NRG Oncology
ARIAN
Fundación GECP
PHITT
University of Birmingham
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
NRG Oncology
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
NRG Oncology
NADIM-ADJUVANT
Fundación GECP
A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy
Shanghai Children's Medical Center
Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC
Stanford University
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
NRG Oncology
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
NRG Oncology
SASCIA
GBG Forschungs GmbH
BEATcc
Grupo Español de Investigación en Cáncer de Ovario
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
Icahn School of Medicine at Mount Sinai
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NRG Oncology
NIRVANA-LUNG
UNICANCER
CRYOMUNE
Institut Bergonié
TRIPLEX
Norwegian University of Science and Technology
Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
DREAM3R
PrECOG, LLC.
ESO-Nanjing7
Jiangsu Cancer Institute & Hospital
Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer
Sun Yat-sen University
SALVOVAR
ARCAGY/ GINECO GROUP
SWENOTECA-ABC
St. Olavs Hospital
PANSY
Fudan University
ELDERLY
Intergroupe Francophone de Cancerologie Thoracique
TOP
Sun Yat-sen University
Pola-R-ICE
GWT-TUD GmbH
NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
Lund University Hospital
Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
AGO Study Group
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
St. Jude Children's Research Hospital
NAUTICAL
University Health Network, Toronto
TCTN
Shanghai Jiao Tong University School of Medicine
ESO-Nanjing12
Jiangsu Cancer Institute & Hospital
Omitting CTV for Primary Tumor in LS-SCLC
Sun Yat-sen University
Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer
Assiut University
AtTEnd
Mario Negri Institute for Pharmacological Research
ProBio
Karolinska Institutet
CITRINE
Fudan University
EURTAC
Spanish Lung Cancer Group
Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer
Women's Hospital School Of Medicine Zhejiang University
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
Alliance for Clinical Trials in Oncology
Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist(Diphenhydramine)in Advanced and Metastatic Non-Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
INTERLACE
University College, London
Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline
Huazhong University of Science and Technology
Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
ANITA
Grupo Español de Investigación en Cáncer de Ovario
Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol
Women's Cancer Care Associates, LLC
Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC
Shanghai Junshi Bioscience Co., Ltd.